Skip to content

Add-on Complex Ayurvedic Treatment in Fibromyalgia-Syndrome Compared to Standard Care Alone

Kontrollierte Klinische Nicht-randomisierte Pilotstudie Zur Komplexen Āyurveda-Therapie Beim Fibromyalgiesyndrom im Vergleich Zur Konventionellen Standardbehandlung

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01389336
Acronym
KAFA
Enrollment
31
Registered
2011-07-08
Start date
2011-07-31
Completion date
2013-05-31
Last updated
2013-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia Syndrome

Keywords

Fibromyalgia Syndrome, Fibromyalgia, Ayurveda, Traditional Indian Medicine, CAM, Pain, Chronic Widespread Pain

Brief summary

The aim of this study is to evaluate the effectiveness of an additive complex āyurvedic diagnosis and treatment compared to conventional standard care alone in stationary patients with Fibromyalgia Syndrome.

Interventions

None listed

Sponsors

Dr.Heinz Horst Deichmann Foundation,Essen,Germany
CollaboratorUNKNOWN
Andreas Michalsen
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* informed consent * age between 18 and 70 years * FMS according to current guidelines

Exclusion criteria

* change of pharmacological FMS treatment \>= 6 weeks before inclusion * pregnancy or breat feeding * acute psychiatric condition * severe acute somatic disease * severechronic comorbidity * obesity WHO \>= II degree * bloodcoagulation-disease * intake of opiods * current treatment with hyperthermia * simultaneous participant in other trial * praticipation in other trial during 6 month before inclusion

Design outcomes

Primary

MeasureTime frameDescription
Fibromyalgia Impact Questionnaire (FIQ)max. 3 weeksChange in FIQ after completion of IPD-treatment

Secondary

MeasureTime frame
State Trait Anxiety Inventory (STAI)max. 3 weeks
Profile of Mood States (POMS)max. 3 weeks
Short Form 36 Health Survey (SF-36)max. 3 weeks
Functional Hanover Questionnaire (FFBH)max. 3 weeks
Likert-Scalesmax 3 weeks
FIQ6 month
FFBH, STAI, POMS, SF-36, VAS, Likert-Scales.6 month
VAS for painmax 3 weeks

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 22, 2026